For example, Fu et al. indicated that ovarian cancer was closely associated with dysregulation of the p53 signaling pathway, drug metabolism, tyrosine metabolism, and cell cycle by screening the differentially expressed genes (DEGs) between human ovarian cancer samples and healthy controls based on the microarray data of GSE14407. This evidence concerns the gene TP53 and ovarian carcinoma.